TOBAM’s Astera Labs ALAB Stock Holding History

TOBAM’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.95M	Sell	6,114 -11,669	-66%	-$3.1M	0.72%	44
2026 Q1	$1.95M	Buy	17,783 +5,420	+44%	+$772K	0.51%	56
2025 Q4	$2.06M	Buy	12,363 +6,613	+115%	+$1.11M	0.51%	60
2025 Q3	$1.13M	Buy	+5,750	New	+$946K	0.41%	66

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

TOBAM's ALAB Position: Q2 2026 in Review

TOBAM reduced its Astera Labs (ALAB) stake by 66% in Q2 2026, selling an estimated $3.1M and leaving 6,114 shares worth $2.95M. The position accounts for 0.72% of the portfolio, ranked #44.

TOBAM first reported a position in ALAB in Q3 2025 and has held it in 4 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

TOBAM held 6,114 shares of Astera Labs worth $2.95M as of Q2 2026.
TOBAM sold 11,669 Astera Labs shares in Q2 2026, an estimated $3.1M.
Astera Labs made up 0.72% of TOBAM's portfolio in Q2 2026, its #44 holding.
TOBAM first reported a position in Astera Labs in Q3 2025 and has held it in 4 quarters since.
988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on TOBAM's 13F filing for Q2 2026, filed 31 Jul 2026.